Playback speed
10 seconds
ASCO® GI 2024 Insights: "Evaluating Novel Therapies and ctDNA as a Marker of Response in Curatively Treated Gastrointestinal Cancers With MRD"
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Reetu Mukherji
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Reetu Mukherji
147 views
February 7, 2024
Login to view comments.
Click here to Login